Tenapanor for the Treatment of Hyperphosphatemia in Japanese Hemodialysis Patients: A Randomized Phase 3 Monotherapy Study With an Up-titration Regimen
Masafumi Fukagawa, Natsuki Urano, Kazuaki Ikejiri, Jun Kinoshita, Kaoru Nakanishi, Tadao Akizawa
Topics & Concepts
MedicineKidney diseaseGuidelineHemodialysisHyperphosphatemiaDialysisInternal medicinePathologyParathyroid Disorders and TreatmentsMagnesium in Health and DiseasePharmacological Effects and Toxicity Studies